NCT06655285

Brief Summary

The purpose of this study is to explore the impact of tumor-associated inflammatory adhesion on the prognosis of colon cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
229

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 23, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

October 24, 2024

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 26, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2024

Completed
Last Updated

November 7, 2024

Status Verified

November 1, 2024

Enrollment Period

2 days

First QC Date

October 22, 2024

Last Update Submit

November 6, 2024

Conditions

Keywords

Colon CancerPrognosisTumor-associated inflammatory adhesion

Outcome Measures

Primary Outcomes (3)

  • Overall survival time (OS)

    OS, defined as the time from the first diagnosis to death from any cause or the last follow-up for surviving patients

    up to 10 years

  • Cancer-specific survival time (CSS)

    CSS refers to the duration from diagnosis of a tumor until the patient succumbs to the tumor, excluding deaths from other causes.

    up to 10 years

  • Recurrence free survival time (RFS)

    RFS is the time from the time a patient achieved R0 resection after surgery to the time of recurrence or the end of follow-up.

    up to 10 years

Study Arms (2)

the U.S. National Cancer Center SEER database

SEER\*Stat software (version 8.4.3) collected 17 registries cohort data on colon cancer patients between 2010 and 2019.

Other: This was a retrospective study and no patient intervention was performed.

Chinese multi-center database

Chinese multi-center database includes patients from January 2010 to December 2021 at 3 institutions.

Other: This was a retrospective study and no patient intervention was performed.

Interventions

This was a retrospective study and no patient intervention was performed.

Chinese multi-center databasethe U.S. National Cancer Center SEER database

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study utilized the Chinese multi-center database as well as the SEER 17 registries database. The Chinese multi-center database contains data of patients between January 2010 and December 2021, at 3 institutions. SEER\*Stat software (version 8.4.1.1) was used for collecting 17 registries cohort data on patients diagnosed with NMIBC between 2010 and 2019.

You may qualify if:

  • The patient was pathologically diagnosed as colon adenocarcinoma by endoscopic biopsy before operation.
  • All patients were considered to have tumors invading adjacent organs during surgery
  • All patients underwent radical surgery.

You may not qualify if:

  • \. Patients with distant metastasis, recurrent colon cancer and pT4b CRC were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, 100021, China

Location

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

October 22, 2024

First Posted

October 23, 2024

Study Start

October 24, 2024

Primary Completion

October 26, 2024

Study Completion

October 27, 2024

Last Updated

November 7, 2024

Record last verified: 2024-11

Locations